Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : INCR -- Incara Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Tomato who wrote (161)	3/21/2002 12:13:18 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 196

messages.yahoo.com Having thought more about it (INCR as an investment, given management and their priorities), I sold my shares, into demand at about a buck even and as part of an effort to go somewhat to cash, after that post. I later added this post......... messages.yahoo.com I was interested in catalytic antioxidants. The company has steadfastly refused to take responsibility -- IMO -- for applying sufficient chemistry resources to the project, and has, at the same time, burned cash on the liver project. It looks, to me, that management just plain deserted their shareholders...... that they've elected to take the company down into "restructuring" land. They'll continue to pull salaries, and the company can be reborn. Ugly.